{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:06:20Z","timestamp":1785434780291,"version":"3.56.0"},"reference-count":18,"publisher":"American Society of Hematology","issue":"3","license":[{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2,13]]},"DOI":"10.1182\/bloodadvances.2023012380","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T23:27:33Z","timestamp":1704497253000},"page":"732-735","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":6,"title":["Perioperative management of apixaban in patients with advanced CKD undergoing a planned invasive procedure"],"prefix":"10.1182","volume":"8","author":[{"given":"Gabriella","family":"Hrubesz","sequence":"first","affiliation":[{"name":"1Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Dwyer","sequence":"additional","affiliation":[{"name":"2Analytics, Ottawa Hospital Research Institute, Ottawa, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8543-1859","authenticated-orcid":false,"given":"Daniel I.","family":"McIsaac","sequence":"additional","affiliation":[{"name":"3Department of Anesthesiology and Pain Medicine, University of Ottawa, Ottawa, Canada"},{"name":"4Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9146-2344","authenticated-orcid":false,"given":"Manish M.","family":"Sood","sequence":"additional","affiliation":[{"name":"4Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada"},{"name":"5Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6767-1197","authenticated-orcid":false,"given":"Edward","family":"Clark","sequence":"additional","affiliation":[{"name":"4Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada"},{"name":"5Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5288-0394","authenticated-orcid":false,"given":"James","family":"Douketis","sequence":"additional","affiliation":[{"name":"6Department of Medicine, McMaster University, Hamilton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8296-2972","authenticated-orcid":false,"given":"Marc","family":"Carrier","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, Canada"},{"name":"4Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2405-7912","authenticated-orcid":false,"given":"Joseph R.","family":"Shaw","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, Canada"},{"name":"4Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,1,31]]},"reference":[{"issue":"5","key":"2024021217144384400_bib1","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/j.ajkd.2005.07.044","article-title":"Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients","volume":"46","author":"Genovesi","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2024021217144384400_bib2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1681\/ASN.2007030308","article-title":"Chronic kidney disease increases risk for venous thromboembolism","volume":"19","author":"Wattanakit","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"2024021217144384400_bib3","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ki.2011.223","article-title":"Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"80","author":"Herzog","year":"2011","journal-title":"Kidney Int"},{"issue":"7","key":"2024021217144384400_bib4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1105594","article-title":"Stroke and bleeding in atrial fibrillation with chronic kidney disease","volume":"367","author":"Olesen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"2024021217144384400_bib5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/jcph.633","article-title":"Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban","volume":"56","author":"Chang","year":"2016","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"5","key":"2024021217144384400_bib6","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/jcph.628","article-title":"Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis","volume":"56","author":"Wang","year":"2016","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"5","key":"2024021217144384400_bib7","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1016\/j.chest.2022.07.025","article-title":"Perioperative management of antithrombotic therapy: an American College of Chest Physicians Clinical Practice Guideline","volume":"162","author":"Douketis","year":"2022","journal-title":"Chest"},{"key":"2024021217144384400_bib8","article-title":"Perioperative hemorrhage in the setting of prolonged therapeutic levels of apixaban in acute-on-chronic kidney disease","author":"Kranker","year":"11  2022","journal-title":"American College of Surgeons"},{"issue":"4","key":"2024021217144384400_bib9","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"issue":"11","key":"2024021217144384400_bib10","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/jth.14598","article-title":"Scientific and Standardization Committee Communication: guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: recommendations for standardized reporting of procedural\/surgical bleed risk and patient-specific thromboembolic risk","volume":"17","author":"Spyropoulos","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"2024021217144384400_bib11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients","volume":"8","author":"Schulman","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"11","key":"2024021217144384400_bib12","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from\u00a0the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"2024021217144384400_bib13","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"2024021217144384400_bib14","first-page":"119","article-title":"Approximate is better than 'exact' for interval estimation of binominal proportions","volume":"52","author":"Agresti","year":"1998","journal-title":"Am Statistician"},{"issue":"13","key":"2024021217144384400_bib15","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1001\/jama.1983.03330370053031","article-title":"If nothing goes wrong, is everything all right? Interpreting zero numerators","volume":"249","author":"Hanley","year":"1983","journal-title":"JAMA"},{"key":"2024021217144384400_bib16","unstructured":"Eliquis (apixaban). Package insert. FDA Product Monograph Bristol-Myers Squibb U.S. Food and Drug Administration website. Revised April 2021. Accessed 8 August 2023. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/202155s034lbl.pdf."},{"issue":"11","key":"2024021217144384400_bib17","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jamainternmed.2019.2431","article-title":"Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant","volume":"179","author":"Douketis","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"9","key":"2024021217144384400_bib18","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1501035","article-title":"Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation","volume":"373","author":"Douketis","year":"2015","journal-title":"N\u00a0Engl J Med"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/3\/732\/2212852\/blooda_adv-2023-012380-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/3\/732\/2212852\/blooda_adv-2023-012380-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T17:15:03Z","timestamp":1707758103000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/3\/732\/506971\/Perioperative-management-of-apixaban-in-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,31]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,2,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023012380","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,31]]}}}